Response to neoadjuvant chemotherapy in ICON8: A GCIG phase III randomised trial evaluating weekly dose-dense chemotherapy integration in first-line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment

Bibliográfalaš dieđut
Váldodahkkit:	Clamp, A, McNeish, I, Dean, A, Gallardo-Rincon, D, Kim, J, O'Donnell, D, Hook, J, Blagden, S, Brenton, J, Naik, R, Perren, T, Sundar, S, Cook, A, James, E, Gabra, H, Lord, R, Hall, M, Dark, G, Kaplan, R, Ledermann, J
Materiálatiipa:	Conference item
Almmustuhtton:	Oxford University Press 2018

Geahča maid